ELI LILLY AND COMPANY |
Market Closed -
Other stock markets
|
After market 06:51:49 pm | |||
| 781.1 USD | +5.95% |
|
771.8 | -1.19% |
| Apr. 30 | Equity Markets Drop Ahead of Fed Rate Decision | MT |
| Apr. 30 | US Equity Markets Close Down Tuesday After Higher Wage Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
Pharmaceuticals
Calendar
2024-05-06
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
27
Last Close Price
737.2
USD
Average target price
814.9
USD
Spread / Average Target
+10.53%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +34.00% | 664B | |
| +29.29% | 567B | |
| -7.75% | 354B | |
| +18.53% | 330B | |
| +4.95% | 286B | |
| +13.79% | 234B | |
| +4.93% | 199B | |
| -9.78% | 196B | |
| -4.89% | 148B | |
| -11.01% | 145B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- European Medicines Agency Finds No Increased Suicide Risk Linked to Weight-loss Drugs
